speb/financial-data huggingface dataset:
HCAI balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 5201008.00
HCAI cash_flow (annual, 2025-12-31) — Common Stock Issuance: 5422746.00
HCAI income_statement (annual, 2025-12-31) — Cost Of Revenue: 6166197.00
HCAI balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 73638.00
HCAI balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 73638.00
HCAI balance_sheet (annual, 2025-12-31) — Current Assets: 11951731.00
HCAI balance_sheet (quarterly, 2025-12-31) — Current Assets: 11951731.00
HCAI balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 24229.00
HCAI balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 24229.00
HCAI balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 24229.00
HCAI balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 24229.00
HCAI balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 21587.00
HCAI balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 21587.00
HCAI balance_sheet (annual, 2025-12-31) — Current Liabilities: 6772122.00
HCAI balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 6772122.00
HCAI cash_flow (annual, 2025-12-31) — Depreciation: 8809.00
HCAI cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 8809.00
HCAI cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 8809.00
HCAI income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -42249434.00
HCAI income_statement (annual, 2025-12-31) — EBIT: -21219820.00
HCAI income_statement (annual, 2025-12-31) — EBITDA: -21211011.00
HCAI cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 183171.00
HCAI cash_flow (annual, 2025-12-31) — End Cash Position: 47608.00
HCAI cash_flow (annual, 2025-12-31) — Financing Cash Flow: 270758.00
HCAI cash_flow (annual, 2025-12-31) — Free Cash Flow: -1301620.00
HCAI cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: 22119583.00
HCAI income_statement (annual, 2025-12-31) — Gain On Sale Of Business: -22119583.00
HCAI balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 48321.00
HCAI balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 48321.00
HCAI income_statement (annual, 2025-12-31) — General And Administrative Expense: 21628718.00
HCAI balance_sheet (annual, 2025-12-31) — Gross PPE: 39552.00
HCAI balance_sheet (quarterly, 2025-12-31) — Gross PPE: 39552.00
HCAI income_statement (annual, 2025-12-31) — Gross Profit: 408898.00
HCAI balance_sheet (annual, 2025-12-31) — Income Tax Payable: 2924.00
HCAI balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 2924.00
HCAI income_statement (annual, 2025-12-31) — Interest Income: 196.00
HCAI income_statement (annual, 2025-12-31) — Interest Income Non Operating: 196.00
HCAI cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 1281.00
HCAI balance_sheet (annual, 2025-12-31) — Invested Capital: 5201008.00
HCAI balance_sheet (quarterly, 2025-12-31) — Invested Capital: 5201008.00
HCAI cash_flow (annual, 2025-12-31) — Investing Cash Flow: 0.00
HCAI cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 5422746.00
HCAI balance_sheet (annual, 2025-12-31) — Liabilities Heldfor Sale Non Current: 0.00
HCAI balance_sheet (quarterly, 2025-12-31) — Liabilities Heldfor Sale Non Current: 0.00
HCAI balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 18735.00
HCAI balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 18735.00
HCAI balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 18735.00
HCAI balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 18735.00
HCAI balance_sheet (annual, 2025-12-31) — Minority Interest: -582.00
HCAI balance_sheet (quarterly, 2025-12-31) — Minority Interest: -582.00
HCAI income_statement (annual, 2025-12-31) — Minority Interests: -331044.00
HCAI cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 5422746.00
HCAI income_statement (annual, 2025-12-31) — Net Income: -42249434.00
HCAI income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -42249434.00
HCAI income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -43343515.00
HCAI income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 1425125.00
HCAI income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -42249434.00
HCAI income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -43674559.00
HCAI cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -43343515.00
HCAI income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -41918390.00
HCAI income_statement (annual, 2025-12-31) — Net Interest Income: 196.00
HCAI cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -4723256.00
HCAI income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 196.00
HCAI balance_sheet (annual, 2025-12-31) — Net PPE: 39552.00
HCAI balance_sheet (quarterly, 2025-12-31) — Net PPE: 39552.00
HCAI cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -4723256.00
HCAI balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 5201008.00
HCAI balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 5201008.00
HCAI income_statement (annual, 2025-12-31) — Normalized EBITDA: 908572.00
HCAI income_statement (annual, 2025-12-31) — Normalized Income: -27084871.75
HCAI cash_flow (annual, 2025-12-31) — Operating Cash Flow: -1301620.00
HCAI cash_flow (annual, 2025-12-31) — Operating Gains Losses: 22119583.00
HCAI income_statement (annual, 2025-12-31) — Operating Income: -21219820.00
HCAI income_statement (annual, 2025-12-31) — Operating Revenue: 6575095.00
HCAI balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1163275.00
HCAI balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1163275.00
HCAI balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 48321.00
HCAI balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 48321.00
HCAI income_statement (annual, 2025-12-31) — Other Gand A: 21628718.00
HCAI income_statement (annual, 2025-12-31) — Other Income Expense: -22121047.00
HCAI income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -1464.00
HCAI balance_sheet (annual, 2025-12-31) — Other Receivables: 60333.00
HCAI balance_sheet (quarterly, 2025-12-31) — Other Receivables: 60333.00
HCAI balance_sheet (annual, 2025-12-31) — Payables: 6652668.00
HCAI balance_sheet (quarterly, 2025-12-31) — Payables: 6652668.00
HCAI balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 6726306.00
HCAI balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 6726306.00
HCAI balance_sheet (annual, 2025-12-31) — Prepaid Assets: 4820195.00
HCAI balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 4820195.00
HCAI income_statement (annual, 2025-12-31) — Pretax Income: -43340671.00
HCAI balance_sheet (annual, 2025-12-31) — Properties: 0.00
HCAI balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
HCAI balance_sheet (annual, 2025-12-31) — Receivables: 7131147.00
HCAI balance_sheet (quarterly, 2025-12-31) — Receivables: 7131147.00
HCAI income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 6166197.00
HCAI income_statement (annual, 2025-12-31) — Reconciled Depreciation: 8809.00
HCAI cash_flow (annual, 2025-12-31) — Repayment Of Debt: -4723256.00
HCAI balance_sheet (annual, 2025-12-31) — Retained Earnings: -25043811.00
HCAI balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -25043811.00
HCAI income_statement (annual, 2025-12-31) — Selling General And Administration: 21628718.00
HCAI balance_sheet (annual, 2025-12-31) — Share Issued: 1163275.00
HCAI balance_sheet (quarterly, 2025-12-31) — Share Issued: 1163275.00
HCAI cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -4723256.00
HCAI income_statement (annual, 2025-12-31) — Special Income Charges: -22119583.00
HCAI cash_flow (annual, 2025-12-31) — Stock Based Compensation: 20910833.00
HCAI balance_sheet (annual, 2025-12-31) — Stockholders Equity: 5201008.00
HCAI balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 5201008.00
HCAI balance_sheet (annual, 2025-12-31) — Tangible Book Value: 5201008.00
HCAI balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 5201008.00
HCAI income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -5529895.75
HCAI income_statement (annual, 2025-12-31) — Tax Provision: 2844.00
HCAI income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.25
HCAI balance_sheet (annual, 2025-12-31) — Total Assets: 11991283.00
HCAI balance_sheet (quarterly, 2025-12-31) — Total Assets: 11991283.00
HCAI balance_sheet (annual, 2025-12-31) — Total Capitalization: 5201008.00
HCAI balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 5201008.00
HCAI balance_sheet (annual, 2025-12-31) — Total Debt: 42964.00
HCAI balance_sheet (quarterly, 2025-12-31) — Total Debt: 42964.00
HCAI balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 5200426.00
HCAI balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 5200426.00
HCAI income_statement (annual, 2025-12-31) — Total Expenses: 27794915.00
HCAI balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 6790857.00
HCAI balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 6790857.00
HCAI balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 39552.00
HCAI balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 39552.00
HCAI balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 18735.00
HCAI balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 18735.00
HCAI income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -21628718.00
HCAI balance_sheet (annual, 2025-12-31) — Total Tax Payable: 59531.00
HCAI balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 59531.00
HCAI income_statement (annual, 2025-12-31) — Total Unusual Items: -22119583.00
HCAI income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -22119583.00
HCAI balance_sheet (annual, 2025-12-31) — Working Capital: 5179609.00
HCAI balance_sheet (quarterly, 2025-12-31) — Working Capital: 5179609.00
HCAT balance_sheet (annual, 2021-12-31) — Additional Paid In Capital: 1400972000.00
HCAT cash_flow (annual, 2021-12-31) — Common Stock Issuance: 245180000.00
HCAT cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 138000.00
HCAT cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 245180000.00
HCAT cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -6290000.00
HCAT cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 0.00
HCAT cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 0.00
HCAT balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 4576000.00
HCAT income_statement (annual, 2021-12-31) — Otherunder Preferred Stock Dividend: 0.00
HCAT cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 0.00
HCAT balance_sheet (annual, 2021-12-31) — Prepaid Assets: 14609000.00
HCAT cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
HCAT cash_flow (annual, 2021-12-31) — Short Term Debt Payments: 0.00
HCAT income_statement (annual, 2021-12-31) — Total Other Finance Cost: 16458000.00
HCAT income_statement (annual, 2022-12-31) — +Operating Expense: 273192000.00
HCAT income_statement (annual, 2022-12-31) — +Total Revenue: 276236000.00
HCAT balance_sheet (annual, 2022-12-31) — Accounts Payable: 4424000.00
HCAT balance_sheet (annual, 2022-12-31) — Accounts Receivable: 47970000.00
HCAT balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -17457000.00
HCAT balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -2300000.00
HCAT cash_flow (annual, 2022-12-31) — Amortization Of Securities: -2236000.00
HCAT cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 5023000.00
HCAT income_statement (annual, 2022-12-31) — Basic Average Shares: 53722000.00
HCAT income_statement (annual, 2022-12-31) — Basic EPS: -2.56
HCAT cash_flow (annual, 2022-12-31) — Beginning Cash Position: 193227000.00
HCAT cash_flow (annual, 2022-12-31) — Capital Expenditure: -17414000.00
HCAT cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -12987000.00
HCAT balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 21451000.00
HCAT balance_sheet (annual, 2022-12-31) — Capital Stock: 1424681000.00
HCAT balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 116312000.00
HCAT balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 363490000.00
HCAT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -2613000.00
HCAT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -39021000.00
HCAT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -35270000.00
HCAT cash_flow (annual, 2022-12-31) — Change In Account Payable: -4702000.00
HCAT cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -3518000.00
HCAT cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -5997000.00
HCAT cash_flow (annual, 2022-12-31) — Change In Payable: -4702000.00
HCAT cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -4702000.00
HCAT cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -478000.00
HCAT cash_flow (annual, 2022-12-31) — Change In Receivables: 788000.00
HCAT cash_flow (annual, 2022-12-31) — Change In Working Capital: -13907000.00
HCAT cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 788000.00
HCAT cash_flow (annual, 2022-12-31) — Changes In Cash: -76904000.00
HCAT balance_sheet (annual, 2022-12-31) — Common Stock: 1424681000.00
HCAT balance_sheet (annual, 2022-12-31) — Common Stock Equity: 425010000.00
HCAT cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
HCAT cash_flow (annual, 2022-12-31) — Common Stock Payments: -8393000.00
HCAT income_statement (annual, 2022-12-31) — Cost Of Revenue: 143049000.00
HCAT balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 7511000.00
HCAT balance_sheet (annual, 2022-12-31) — Current Assets: 427795000.00
HCAT balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 3434000.00
HCAT balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 3434000.00
HCAT balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 54961000.00
HCAT balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 54961000.00
HCAT balance_sheet (annual, 2022-12-31) — Current Liabilities: 82510000.00
HCAT cash_flow (annual, 2022-12-31) — Deferred Income Tax: -4523000.00
HCAT cash_flow (annual, 2022-12-31) — Deferred Tax: -4523000.00
HCAT cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 48297000.00
HCAT income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 48297000.00
HCAT cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 48297000.00
HCAT income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 48297000.00
HCAT income_statement (annual, 2022-12-31) — Diluted Average Shares: 54080000.00
HCAT income_statement (annual, 2022-12-31) — Diluted EPS: -2.63
HCAT income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -137403000.00
HCAT income_statement (annual, 2022-12-31) — EBIT: -140005000.00
HCAT income_statement (annual, 2022-12-31) — EBITDA: -91708000.00
HCAT cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -11000.00
HCAT cash_flow (annual, 2022-12-31) — End Cash Position: 116312000.00
HCAT cash_flow (annual, 2022-12-31) — Financing Cash Flow: -2613000.00
HCAT cash_flow (annual, 2022-12-31) — Free Cash Flow: -52684000.00
HCAT balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -648000.00
HCAT income_statement (annual, 2022-12-31) — General And Administrative Expense: 61701000.00
HCAT balance_sheet (annual, 2022-12-31) — Goodwill: 185982000.00
HCAT balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 278171000.00
HCAT balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 50270000.00
HCAT balance_sheet (annual, 2022-12-31) — Gross PPE: 60043000.00
HCAT income_statement (annual, 2022-12-31) — Gross Profit: 133187000.00
HCAT cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 297000.00
HCAT income_statement (annual, 2022-12-31) — Interest Expense: 7239000.00
HCAT income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 7239000.00
HCAT income_statement (annual, 2022-12-31) — Interest Income: 5687000.00
HCAT income_statement (annual, 2022-12-31) — Interest Income Non Operating: 5687000.00
HCAT cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 5750000.00
HCAT balance_sheet (annual, 2022-12-31) — Invested Capital: 651533000.00
HCAT cash_flow (annual, 2022-12-31) — Investing Cash Flow: -39021000.00
HCAT cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
HCAT cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
HCAT balance_sheet (annual, 2022-12-31) — Leases: 9969000.00
HCAT balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 18017000.00
HCAT balance_sheet (annual, 2022-12-31) — Long Term Debt: 226523000.00
HCAT balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 244540000.00
HCAT cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
HCAT cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
HCAT balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 33416000.00
HCAT cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -27846000.00
HCAT cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -8393000.00
HCAT balance_sheet (annual, 2022-12-31) — Net Debt: 110211000.00
HCAT income_statement (annual, 2022-12-31) — Net Income: -137403000.00
HCAT income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -137403000.00
HCAT income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -137403000.00
HCAT income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -137403000.00
HCAT income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -137403000.00
HCAT cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -137403000.00
HCAT income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -137403000.00
HCAT cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -2260000.00
HCAT income_statement (annual, 2022-12-31) — Net Interest Income: -1678000.00
HCAT cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 6210000.00
HCAT cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
HCAT cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
HCAT income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -1678000.00
HCAT cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -1342000.00
HCAT balance_sheet (annual, 2022-12-31) — Net PPE: 42586000.00
HCAT cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -2138000.00
HCAT cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
HCAT balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 146839000.00
HCAT balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 105000.00
HCAT balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 105000.00
HCAT income_statement (annual, 2022-12-31) — Normalized EBITDA: -91708000.00
HCAT income_statement (annual, 2022-12-31) — Normalized Income: -137403000.00
HCAT cash_flow (annual, 2022-12-31) — Operating Cash Flow: -35270000.00
HCAT income_statement (annual, 2022-12-31) — Operating Income: -140005000.00
HCAT income_statement (annual, 2022-12-31) — Operating Revenue: 276236000.00
HCAT balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 55261922.00
HCAT balance_sheet (annual, 2022-12-31) — Other Current Assets: 16335000.00
HCAT balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -648000.00
HCAT income_statement (annual, 2022-12-31) — Other Gand A: 61701000.00
HCAT income_statement (annual, 2022-12-31) — Other Income Expense: -126000.00
HCAT balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 92189000.00
HCAT cash_flow (annual, 2022-12-31) — Other Non Cash Items: -3316000.00
HCAT balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 3734000.00
HCAT balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 121000.00
HCAT income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -126000.00
HCAT balance_sheet (annual, 2022-12-31) — Other Properties: 16658000.00
HCAT balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 247178000.00
HCAT balance_sheet (annual, 2022-12-31) — Payables: 4424000.00
HCAT balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 11935000.00
HCAT balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 12180000.00
HCAT balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
HCAT income_statement (annual, 2022-12-31) — Pretax Income: -141683000.00
HCAT cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 7122000.00
HCAT balance_sheet (annual, 2022-12-31) — Properties: 0.00
HCAT cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 691000.00
HCAT cash_flow (annual, 2022-12-31) — Purchase Of Business: -27846000.00
HCAT cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -2260000.00
HCAT cash_flow (annual, 2022-12-31) — Purchase Of Investment: -308961000.00
HCAT cash_flow (annual, 2022-12-31) — Purchase Of PPE: -2167000.00
HCAT balance_sheet (annual, 2022-12-31) — Receivables: 47970000.00
HCAT income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 143049000.00
HCAT income_statement (annual, 2022-12-31) — Reconciled Depreciation: 48297000.00
HCAT cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
HCAT cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -8393000.00
HCAT income_statement (annual, 2022-12-31) — Research And Development: 75680000.00
HCAT balance_sheet (annual, 2022-12-31) — Retained Earnings: -999023000.00
HCAT cash_flow (annual, 2022-12-31) — Sale Of Investment: 315171000.00
HCAT cash_flow (annual, 2022-12-31) — Sale Of PPE: 29000.00
HCAT income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 87514000.00
HCAT income_statement (annual, 2022-12-31) — Selling General And Administration: 149215000.00
HCAT balance_sheet (annual, 2022-12-31) — Share Issued: 55261922.00
HCAT cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
HCAT income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
HCAT cash_flow (annual, 2022-12-31) — Stock Based Compensation: 72104000.00
HCAT balance_sheet (annual, 2022-12-31) — Stockholders Equity: 425010000.00
HCAT balance_sheet (annual, 2022-12-31) — Tangible Book Value: 146839000.00
HCAT income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
HCAT income_statement (annual, 2022-12-31) — Tax Provision: -4280000.00
HCAT income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.03
HCAT balance_sheet (annual, 2022-12-31) — Total Assets: 752286000.00
HCAT balance_sheet (annual, 2022-12-31) — Total Capitalization: 651533000.00
HCAT balance_sheet (annual, 2022-12-31) — Total Debt: 247974000.00
HCAT balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 425010000.00
HCAT income_statement (annual, 2022-12-31) — Total Expenses: 416241000.00
HCAT balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 327276000.00
HCAT balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 324491000.00
HCAT balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 244766000.00
HCAT income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -140005000.00
HCAT income_statement (annual, 2022-12-31) — Total Other Finance Cost: 1678000.00
HCAT income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
HCAT income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
HCAT balance_sheet (annual, 2022-12-31) — Working Capital: 345285000.00
HCAT income_statement (annual, 2023-12-31) — +Operating Expense: 231832000.00
HCAT income_statement (annual, 2023-12-31) — +Total Revenue: 295938000.00
HCAT balance_sheet (annual, 2023-12-31) — Accounts Payable: 6641000.00
HCAT balance_sheet (annual, 2023-12-31) — Accounts Receivable: 60290000.00
HCAT balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -27357000.00
HCAT balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -4105000.00
HCAT cash_flow (annual, 2023-12-31) — Amortization Of Securities: -9720000.00
HCAT cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 4081000.00
HCAT income_statement (annual, 2023-12-31) — Basic Average Shares: 56418000.00
HCAT income_statement (annual, 2023-12-31) — Basic EPS: -2.09
HCAT cash_flow (annual, 2023-12-31) — Beginning Cash Position: 116312000.00
HCAT cash_flow (annual, 2023-12-31) — Capital Expenditure: -14311000.00
HCAT cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -11957000.00
HCAT balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 21034000.00
HCAT balance_sheet (annual, 2023-12-31) — Capital Stock: 1484056000.00
HCAT balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 106276000.00
HCAT balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 317728000.00
HCAT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 2730000.00
HCAT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 20293000.00
HCAT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -33080000.00
HCAT cash_flow (annual, 2023-12-31) — Change In Account Payable: 4868000.00
HCAT cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -3552000.00
HCAT cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -1487000.00
HCAT cash_flow (annual, 2023-12-31) — Change In Payable: 4868000.00
HCAT cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 4868000.00
HCAT cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 164000.00
HCAT cash_flow (annual, 2023-12-31) — Change In Receivables: -13663000.00
HCAT cash_flow (annual, 2023-12-31) — Change In Working Capital: -13670000.00
HCAT cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -13663000.00
HCAT cash_flow (annual, 2023-12-31) — Changes In Cash: -10057000.00
HCAT balance_sheet (annual, 2023-12-31) — Common Stock: 1484056000.00
HCAT balance_sheet (annual, 2023-12-31) — Common Stock Equity: 366919000.00
HCAT cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
HCAT cash_flow (annual, 2023-12-31) — Common Stock Payments: -1808000.00
HCAT income_statement (annual, 2023-12-31) — Cost Of Revenue: 164105000.00
HCAT balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 11602000.00
HCAT balance_sheet (annual, 2023-12-31) — Current Assets: 393397000.00
HCAT balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 3358000.00
HCAT balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 3358000.00
HCAT balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 55753000.00
HCAT balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 55753000.00
HCAT balance_sheet (annual, 2023-12-31) — Current Liabilities: 89034000.00
HCAT cash_flow (annual, 2023-12-31) — Deferred Income Tax: 8000.00
HCAT cash_flow (annual, 2023-12-31) — Deferred Tax: 8000.00
HCAT cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 42223000.00
HCAT income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 42223000.00
HCAT cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 42223000.00
HCAT income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 42223000.00
HCAT income_statement (annual, 2023-12-31) — Diluted Average Shares: 56418000.00
HCAT income_statement (annual, 2023-12-31) — Diluted EPS: -2.09
HCAT income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -118147000.00
HCAT income_statement (annual, 2023-12-31) — EBIT: -99999000.00
HCAT income_statement (annual, 2023-12-31) — EBITDA: -57776000.00
HCAT cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 21000.00
HCAT cash_flow (annual, 2023-12-31) — End Cash Position: 106276000.00
HCAT cash_flow (annual, 2023-12-31) — Financing Cash Flow: 2730000.00
HCAT cash_flow (annual, 2023-12-31) — Free Cash Flow: -47391000.00
HCAT balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 33000.00
HCAT income_statement (annual, 2023-12-31) — General And Administrative Expense: 52773000.00
HCAT balance_sheet (annual, 2023-12-31) — Goodwill: 190652000.00
HCAT balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 264036000.00
HCAT balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 64395000.00
HCAT balance_sheet (annual, 2023-12-31) — Gross PPE: 66996000.00
HCAT income_statement (annual, 2023-12-31) — Gross Profit: 131833000.00
HCAT income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
HCAT cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 266000.00
HCAT income_statement (annual, 2023-12-31) — Interest Expense: 7287000.00
HCAT income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 7287000.00
HCAT income_statement (annual, 2023-12-31) — Interest Income: 16389000.00
HCAT income_statement (annual, 2023-12-31) — Interest Income Non Operating: 16389000.00
HCAT cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 5750000.00
HCAT balance_sheet (annual, 2023-12-31) — Interest Payable: 1090000.00
HCAT balance_sheet (annual, 2023-12-31) — Invested Capital: 594953000.00
HCAT cash_flow (annual, 2023-12-31) — Investing Cash Flow: 20293000.00
HCAT cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
HCAT cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
HCAT balance_sheet (annual, 2023-12-31) — Leases: 8814000.00
HCAT balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 17676000.00
HCAT balance_sheet (annual, 2023-12-31) — Long Term Debt: 228034000.00
HCAT balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 245710000.00
HCAT cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
HCAT cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
HCAT balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 44255000.00
HCAT cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -11392000.00
HCAT cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -1808000.00
HCAT balance_sheet (annual, 2023-12-31) — Net Debt: 121758000.00
HCAT income_statement (annual, 2023-12-31) — Net Income: -118147000.00
HCAT income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -118147000.00
HCAT income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -118147000.00
HCAT income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -118147000.00
HCAT income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -118147000.00
HCAT cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -118147000.00
HCAT income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -118147000.00
HCAT cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -1118000.00
HCAT income_statement (annual, 2023-12-31) — Net Interest Income: 9106000.00
HCAT cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 45965000.00
HCAT cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
HCAT cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
HCAT income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 9106000.00
HCAT balance_sheet (annual, 2023-12-31) — Net PPE: 39639000.00
HCAT cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -1205000.00
HCAT balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 102883000.00
HCAT balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 77000.00
HCAT balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 77000.00
HCAT income_statement (annual, 2023-12-31) — Normalized EBITDA: -30878000.00
HCAT income_statement (annual, 2023-12-31) — Normalized Income: -96897580.00
HCAT cash_flow (annual, 2023-12-31) — Operating Cash Flow: -33080000.00
HCAT income_statement (annual, 2023-12-31) — Operating Income: -99999000.00
HCAT income_statement (annual, 2023-12-31) — Operating Revenue: 295938000.00
HCAT balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 58295491.00
HCAT balance_sheet (annual, 2023-12-31) — Other Current Assets: 15379000.00
HCAT balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 33000.00
HCAT income_statement (annual, 2023-12-31) — Other Gand A: 52773000.00
HCAT income_statement (annual, 2023-12-31) — Other Income Expense: -26898000.00
HCAT balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 73384000.00
HCAT cash_flow (annual, 2023-12-31) — Other Non Cash Items: 4568000.00
HCAT balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 4742000.00
HCAT balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 74000.00
HCAT income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 4000.00
HCAT balance_sheet (annual, 2023-12-31) — Other Properties: 13927000.00
HCAT balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 211452000.00
HCAT income_statement (annual, 2023-12-31) — Other Special Charges: 25360000.00
HCAT balance_sheet (annual, 2023-12-31) — Payables: 6641000.00
HCAT balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 18243000.00
HCAT balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 11680000.00
HCAT balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
HCAT income_statement (annual, 2023-12-31) — Pretax Income: -117791000.00
HCAT cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 4538000.00
HCAT balance_sheet (annual, 2023-12-31) — Properties: 0.00
HCAT cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 1821000.00
HCAT cash_flow (annual, 2023-12-31) — Purchase Of Business: -11392000.00
HCAT cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -1118000.00
HCAT cash_flow (annual, 2023-12-31) — Purchase Of Investment: -290836000.00
HCAT cash_flow (annual, 2023-12-31) — Purchase Of PPE: -1236000.00
HCAT balance_sheet (annual, 2023-12-31) — Receivables: 60290000.00
HCAT income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 164105000.00
HCAT income_statement (annual, 2023-12-31) — Reconciled Depreciation: 42223000.00
HCAT cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
HCAT cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -1808000.00
HCAT income_statement (annual, 2023-12-31) — Research And Development: 72627000.00
HCAT income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 1538000.00
HCAT balance_sheet (annual, 2023-12-31) — Retained Earnings: -1117170000.00
HCAT cash_flow (annual, 2023-12-31) — Sale Of Investment: 336801000.00
HCAT cash_flow (annual, 2023-12-31) — Sale Of PPE: 31000.00
HCAT income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 64209000.00
HCAT income_statement (annual, 2023-12-31) — Selling General And Administration: 116982000.00
HCAT balance_sheet (annual, 2023-12-31) — Share Issued: 58295491.00
HCAT income_statement (annual, 2023-12-31) — Special Income Charges: -26898000.00
HCAT cash_flow (annual, 2023-12-31) — Stock Based Compensation: 55756000.00
HCAT balance_sheet (annual, 2023-12-31) — Stockholders Equity: 366919000.00
HCAT balance_sheet (annual, 2023-12-31) — Tangible Book Value: 102883000.00
HCAT income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -5648580.00
HCAT income_statement (annual, 2023-12-31) — Tax Provision: 356000.00
HCAT income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
HCAT balance_sheet (annual, 2023-12-31) — Total Assets: 701814000.00
HCAT balance_sheet (annual, 2023-12-31) — Total Capitalization: 594953000.00
HCAT balance_sheet (annual, 2023-12-31) — Total Debt: 249068000.00
HCAT balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 366919000.00
HCAT income_statement (annual, 2023-12-31) — Total Expenses: 395937000.00
HCAT balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 334895000.00
HCAT balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 308417000.00
HCAT balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 245861000.00
HCAT income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -126897000.00
HCAT income_statement (annual, 2023-12-31) — Total Other Finance Cost: -9106000.00
HCAT income_statement (annual, 2023-12-31) — Total Unusual Items: -26898000.00
HCAT income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -26898000.00
HCAT balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
HCAT balance_sheet (annual, 2023-12-31) — Working Capital: 304363000.00
HCAT income_statement (annual, 2024-12-31) — +Operating Expense: 198392000.00
HCAT income_statement (annual, 2024-12-31) — +Total Revenue: 306584000.00
HCAT balance_sheet (annual, 2024-12-31) — Accounts Payable: 11433000.00
HCAT balance_sheet (annual, 2024-12-31) — Accounts Receivable: 57182000.00
HCAT balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -39382000.00
HCAT balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -4200000.00
HCAT cash_flow (annual, 2024-12-31) — Amortization Of Securities: -4757000.00
HCAT cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 2200000.00
HCAT income_statement (annual, 2024-12-31) — Basic Average Shares: 60185000.00
HCAT income_statement (annual, 2024-12-31) — Basic EPS: -1.15
HCAT cash_flow (annual, 2024-12-31) — Beginning Cash Position: 106276000.00
HCAT cash_flow (annual, 2024-12-31) — Capital Expenditure: -16398000.00
HCAT cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -14274000.00
HCAT balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 19905000.00
HCAT balance_sheet (annual, 2024-12-31) — Capital Stock: 1552714000.00
HCAT balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 249645000.00
HCAT balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 392000000.00
HCAT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 151746000.00
HCAT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -22902000.00
HCAT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 14559000.00
HCAT cash_flow (annual, 2024-12-31) — Change In Account Payable: 5581000.00
HCAT cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -3460000.00
HCAT cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -7012000.00
HCAT cash_flow (annual, 2024-12-31) — Change In Payable: 5581000.00
HCAT cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 5581000.00
HCAT cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -50000.00
HCAT cash_flow (annual, 2024-12-31) — Change In Receivables: 4281000.00
HCAT cash_flow (annual, 2024-12-31) — Change In Working Capital: -660000.00
HCAT cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 4281000.00
HCAT cash_flow (annual, 2024-12-31) — Changes In Cash: 143403000.00
HCAT cash_flow (quarterly, 2024-12-31) — Changes In Cash: -78586000.00
HCAT balance_sheet (annual, 2024-12-31) — Common Stock: 1552714000.00
HCAT balance_sheet (annual, 2024-12-31) — Common Stock Equity: 365207000.00
HCAT cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
HCAT income_statement (annual, 2024-12-31) — Cost Of Revenue: 165805000.00
HCAT balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 14685000.00
HCAT balance_sheet (annual, 2024-12-31) — Current Assets: 465650000.00
HCAT balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 3614000.00
HCAT balance_sheet (annual, 2024-12-31) — Current Debt: 231182000.00
HCAT balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 234796000.00
HCAT balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 53281000.00
HCAT balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 53281000.00
HCAT balance_sheet (annual, 2024-12-31) — Current Liabilities: 325850000.00
HCAT cash_flow (annual, 2024-12-31) — Deferred Income Tax: 77000.00
HCAT cash_flow (annual, 2024-12-31) — Deferred Tax: 77000.00
HCAT cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 41431000.00
HCAT income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 41431000.00
HCAT cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 41431000.00
HCAT income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 41431000.00
HCAT income_statement (annual, 2024-12-31) — Diluted Average Shares: 60185000.00
HCAT income_statement (annual, 2024-12-31) — Diluted EPS: -1.15
HCAT income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -69502000.00
HCAT income_statement (annual, 2024-12-31) — EBIT: -52083000.00
HCAT income_statement (annual, 2024-12-31) — EBITDA: -10652000.00
HCAT cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -34000.00
HCAT cash_flow (annual, 2024-12-31) — End Cash Position: 249645000.00
HCAT cash_flow (quarterly, 2024-12-31) — End Cash Position: 249645000.00
HCAT cash_flow (annual, 2024-12-31) — Financing Cash Flow: 151746000.00
HCAT cash_flow (annual, 2024-12-31) — Free Cash Flow: -1839000.00
HCAT balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -835000.00
HCAT income_statement (annual, 2024-12-31) — General And Administrative Expense: 45864000.00
HCAT balance_sheet (annual, 2024-12-31) — Goodwill: 259759000.00
HCAT balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 345811000.00
HCAT balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 61382000.00
HCAT balance_sheet (annual, 2024-12-31) — Gross PPE: 80834000.00
HCAT income_statement (annual, 2024-12-31) — Gross Profit: 140779000.00
HCAT income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
HCAT cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 10119000.00
HCAT income_statement (annual, 2024-12-31) — Interest Expense: 17086000.00
HCAT income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 17086000.00
HCAT income_statement (annual, 2024-12-31) — Interest Income: 17982000.00
HCAT income_statement (annual, 2024-12-31) — Interest Income Non Operating: 17982000.00
HCAT cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 10119000.00
HCAT balance_sheet (annual, 2024-12-31) — Interest Payable: 4803000.00
HCAT balance_sheet (annual, 2024-12-31) — Invested Capital: 747567000.00
HCAT cash_flow (annual, 2024-12-31) — Investing Cash Flow: -22902000.00
HCAT cash_flow (annual, 2024-12-31) — Issuance Of Debt: 152277000.00
HCAT cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 36805000.00
HCAT balance_sheet (annual, 2024-12-31) — Leases: 8456000.00
HCAT balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 16291000.00
HCAT balance_sheet (annual, 2024-12-31) — Long Term Debt: 151178000.00
HCAT balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 167469000.00
HCAT cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 152277000.00
HCAT cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 36805000.00
HCAT cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -959000.00
HCAT balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 60320000.00
HCAT cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -80277000.00
HCAT cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
HCAT balance_sheet (annual, 2024-12-31) — Net Debt: 132715000.00
HCAT income_statement (annual, 2024-12-31) — Net Income: -69502000.00
HCAT income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -69502000.00
HCAT income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -69502000.00
HCAT income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -69502000.00
HCAT income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -69502000.00
HCAT cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -69502000.00
HCAT income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -69502000.00
HCAT cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -508000.00
HCAT income_statement (annual, 2024-12-31) — Net Interest Income: 896000.00
HCAT cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 73760000.00
HCAT cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 151318000.00
HCAT cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 151318000.00
HCAT income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 896000.00
HCAT cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -2152000.00
HCAT cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 848000.00
HCAT balance_sheet (annual, 2024-12-31) — Net PPE: 41452000.00
HCAT cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1603000.00
HCAT balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 19396000.00
HCAT balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 249000.00
HCAT balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 249000.00
HCAT income_statement (annual, 2024-12-31) — Normalized EBITDA: 1541000.00
HCAT income_statement (annual, 2024-12-31) — Normalized Income: -59869530.00
HCAT cash_flow (annual, 2024-12-31) — Operating Cash Flow: 14559000.00
HCAT income_statement (annual, 2024-12-31) — Operating Income: -57613000.00
HCAT income_statement (annual, 2024-12-31) — Operating Revenue: 306584000.00
HCAT balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 64043799.00
HCAT balance_sheet (annual, 2024-12-31) — Other Current Assets: 16468000.00
HCAT balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 231182000.00
HCAT balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -835000.00
HCAT income_statement (annual, 2024-12-31) — Other Gand A: 45864000.00
HCAT income_statement (annual, 2024-12-31) — Other Income Expense: -12452000.00
HCAT balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 86052000.00
HCAT cash_flow (annual, 2024-12-31) — Other Non Cash Items: 4440000.00
HCAT balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 6016000.00
HCAT balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 154000.00
HCAT income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -259000.00
HCAT balance_sheet (annual, 2024-12-31) — Other Properties: 12058000.00
HCAT balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 142355000.00
HCAT income_statement (annual, 2024-12-31) — Other Special Charges: 2200000.00
HCAT balance_sheet (annual, 2024-12-31) — Payables: 11433000.00
HCAT balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 26118000.00
HCAT balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 11655000.00
HCAT balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
HCAT income_statement (annual, 2024-12-31) — Pretax Income: -69169000.00
HCAT cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 2580000.00
HCAT balance_sheet (annual, 2024-12-31) — Properties: 0.00
HCAT cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 1202000.00
HCAT cash_flow (annual, 2024-12-31) — Purchase Of Business: -80277000.00